Recent Advances in the Use of Functional Foods: Effects of the Commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt Strains on Gut Transit Time in the Elderly
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Fermented milk products containing the probiotic strain Bifidobacterium animalis DN-173 010 (BM) have a beneficial effect in reducing gut transit times in a range of populations including adults and the elderly, especially female. The aims of this study were to investigate the efficacy of one and two servings per day of BM in elderly subjects and to determine the duration of the reduction in transit times after stopping consumption of the product. This was a randomized controlled and open study with four groups; 200 elderly subjects (aged 50-75 years) were enrolled in the trial. In all, 100 subjects with medium transit times (MTT, 40-50 h) and 100 with slow transit times (STT, >50 h) were randomized to receive either 125 g or 250 g BM daily for 2 weeks. Oro-faecal gut transit was determined by the use of coloured markers. Both dosages significantly reduced oro-faecal transit time with reductions of 20.5% and 42.2% observed in MTT subjects receiving BM 125 g/day and 250 g/day, respectively ( p <0.0001). Corresponding reductions in STT subjects were 27.7% and 38.1%, respectively. The beneficial effects of BM lasted long after consumption of the product was stopped, with values returning to baseline in subjects with MTT at 6 weeks follow-up and in STT subjects consuming 125 g/day BM at 4 weeks follow-up. Significant differences in transit times were still observed at week 6 of follow-up in STT subjects receiving 250 g/day BM. This study completes and confirms the dose-dependent effects of BM from 0 to 250 g per day and can be compared with similar results obtained with 250 to 375g per day in a previous study on transit times in elderly subjects. It also demonstrates that there are significant beneficial effects long after consumption of the product has stopped. The results suggest an important role for this probiotic dairy product in fundamentally modulating gastrointestinal function that could beneficially affect the host, and hence reduce the susceptibility to conditions associated with delayed gut transit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy adults as well as elderly subjects, a fermented milk containing Bifidobacterium animalis DN-173 010 alone or in association with the yoghurt starters Lactobacillus bulgaricus and Streptococcus thermophilus has been shown to decrease orofecal and ⁄ or colonic, especially sigmoid, transit time; [22][23][24][25]”
Citations
Cites
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Functional food science and gastrointestinal physiology and function
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M., & Rowland, I. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980108 · Cited by 1,398
Fuller, R. (1991) · Gut · doi:10.1136/gut.32.4.439 · Cited by 862
Regulatory effects of bifidobacteria on the growth of other colonic bacteria
Gibson, G. R., & Wang, X. (1994) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1994.tb03443.x · Cited by 682 · cited 1×
“(31) reported that the effects of probiotics might be greater in subjects having initially slow transit times, and this has been confirmed in previous studies evaluating the effects of BM in people with transit times /40 h (26, 27).”
BackgroundEpidemiology of inflammatory bowel disease
Loftus, E. V., & Sandborn, W. J. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00002-4 · Cited by 542
The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
Goldin, B. R., & Gorbach, S. L. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/39.5.756 · Cited by 400 · cited 2×
“It is known that accelerated transit stimulates the growth and activity of the microflora (33).”
BackgroundMarteau, P., Cuillerier, E., Meance, S., Gerhardt, M. F., Myara, A., Bouvier, M., Bouley, C., Tondu, F., Bommelaer, G., & Grimaud, J. C. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01188.x · Cited by 254 · cited 3×
“These results were similar to those obtained in the previous study (26) investigating the dose-response effects of two and three servings of BM daily using the same protocol and methods.”
BackgroundResultEffect of the Normal Microbial Flora on Gastrointestinal Motility.
Abrams, G. D., & Bishop, J. E. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-126-32430 · Cited by 241 · cited 1×
“One proposed mechanism is that increasing the concentration of bifidobacteria in the gut may select microflora strains that are resistant to acid conditions, thus modifying the profile of gut microflora and its metabolites, such as short chain fatty acids, and consequently transit time (9, 10, 32, 33).”
BackgroundBifidobacterium from Fermented Milks: Survival During Gastric Transit
Berrada, N., Lemeland, J.-F., Laroche, G., Thouvenot, P., & Piaia, M. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78183-6 · Cited by 203 · cited 1×
“These include good survival of the strain in the human gastrointestinal tract (17, 18, 21) and health benefits such as enhancement of the IgA antirotavirus responses and antimutagenic properties demonstrated in either animal or in vitro models (22 /24).”
BackgroundPochart, P., Marteau, P., Bouhnik, Y., Goderel, I., Bourlioux, P., & Rambaud, J. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.78 · Cited by 195 · cited 1×
“These include good survival of the strain in the human gastrointestinal tract (17, 18, 21) and health benefits such as enhancement of the IgA antirotavirus responses and antimutagenic properties demonstrated in either animal or in vitro models (22 /24).”
Background
Research works printed but not linked: 17
- McLean Baird I, 1977, Metabolism, 26, 28
- Eastwood MA, 1973, BMJ, 4, 5
- Sacquet E, 1970, CR Seances Soc Biol Fil, 164, 7
- Boriello SP, 1984, Scand J Gastroenterol, 19, 21
- Falk PG, 1998, Microbiol Mol Biol Rev, 62, 70
- Fuller R, 1989, J Appl Bacteriol, 66, 78
- Lee YK, 1995, Trends Food Sci Technol, 6, 5
- Fuller R, 1993, Int Food Ingred, 3, 6
- Tamine AY, 1995, J Dairy Res, 62, 87
- Moreau MC, 1998, Cambridge, 47, 51
- Abdelali H, 1995, Mut Res, 331, 41
- Meance S, 2001, Microb Ecol Health Dis, 13, 22
- Pathmakanthan S, 2000, Microb Ecol Health Dis, 30
- Cummings JH, 1997, Institute Danone Bruzelles, Belgium. Danone Chair Monograph, 2
- Imaizumi K, 2002, J Nutr Sci Vitaminol, 38, 51
- Meier R, 1993, J Parenter Nutr, 17, 5
- Hopper LV, 2001, Science, 291, 4
Cited by
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration
Leeming, E. R., Johnson, A. J., Spector, T. D., & Le Roy, C. I. (2019) · Nutrients · doi:10.3390/nu11122862 · Cited by 817
“On conclusion of the study, the reduced length of transit time observed only returned to baseline at 6-week follow-up for those with a medium transit time (40–50 h), and at 4-week follow-up for those with slow transit times (>50 h) who had been consuming 150 g of BM per day [54].”
BackgroundReview article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
PICARD, C., FIORAMONTI, J., FRANCOIS, A., ROBINSON, T., NEANT, F., & MATUCHANSKY, C. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02615.x · Cited by 618
GUYONNET, D., CHASSANY, O., DUCROTTE, P., PICARD, C., MOURET, M., MERCIER, C. ‐., & MATUCHANSKY, C. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03362.x · Cited by 365
AGRAWAL, A., HOUGHTON, L. A., MORRIS, J., REILLY, B., GUYONNET, D., GOUPIL FEUILLERAT, N., SCHLUMBERGER, A., JAKOB, S., & WHORWELL, P. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03853.x · Cited by 334
Systematic review of randomised controlled trials: probiotics for functional constipation.
Chmielewska, A., & Szajewska, H. (2010) · PubMed · doi:10.3748/wjg.v16.i1.69 · Cited by 211
The inflammatory status of old age can be nurtured from the intestinal environment
Guigoz, Y., Doré, J., & Schiffrin, E. J. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282f2bfdf · Cited by 218
Antioxidant activity of yoghurt peptides: Part 2 – Characterisation of peptide fractions
Sabeena Farvin, K. H., Baron, C. P., Nielsen, N. S., Otte, J., & Jacobsen, C. (2010) · Food Chemistry · doi:10.1016/j.foodchem.2010.05.029 · Cited by 199
Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women
Yang, Y.-X., He, M., Hu, G., Wei, J., Pages, P., Yang, X.-H., & Bourdu-Naturel, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6237 · Cited by 151
“This effect is enhanced with increased daily intake (effect of three pots/d > two pots/d > 1 pot/day) in elderly subjects free of any gastrointestinal pathology[15, 16 ], and in a group of healthy women aged 18-45 years[17].”
BackgroundGuyonnet, D., Schlumberger, A., Mhamdi, L., Jakob, S., & Chassany, O. (2009) · British Journal of Nutrition · doi:10.1017/s0007114509990882 · Cited by 95
Tabbers, M. M., Chmielewska, A., Roseboom, M. G., Crastes, N., Perrin, C., Reitsma, J. B., Norbruis, O., Szajewska, H., & Benninga, M. A. (2011) · Pediatrics · doi:10.1542/peds.2010-2590 · Cited by 93
Roberts, L. M., McCahon, D., Holder, R., Wilson, S., & Hobbs, F. R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-45 · Cited by 88
Understanding gut microbiota in elderly's health will enable intervention through probiotics
Pérez Martínez, G., Bäuerl, C., & Collado, M. C. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0079 · Cited by 76
Eskesen, D., Jespersen, L., Michelsen, B., Whorwell, P. J., Müller-Lissner, S., & Morberg, C. M. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515003347 · Cited by 78
Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool
Gwee, K.-A., Ghoshal, U. C., Gonlachanvit, S., Chua, A. S. B., Myung, S.-J., Rajindrajith, S., Patcharatrakul, T., Choi, M.-G., Wu, J. C. Y., Chen, M.-H., et al. (2013) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2013.19.2.149 · Cited by 77
“clinical end points and study design.(45-52) A potentially important confounding factor that has not been adequately addressed is whether fundamental differences in indigenous gut flora exists”
BackgroundWalker, W. A., Goulet, O., Morelli, L., & Antoine, J. (2006) · European Journal of Nutrition · doi:10.1007/s00394-006-1101-1 · Cited by 71
Self-citationEffect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation
Krammer, H.-J., von Seggern, H., Schaumburg, J., & Neumer, F. (2011) · coloproctology · doi:10.1007/s00053-011-0177-0 · Cited by 54
“In pa tients with normal transit time a clear cor relation of the dosis intake and the effect was shown [24].”
BackgroundPaula, J. A. D., Carmuega, E., & Weill, R. (2008) · PubMed · Cited by 54
Knowledge, use and perceptions of probiotics and prebiotics in hospitalised patients
Betz, M. V., Uzueta, A., Rasmussen, H. E., Gregoire, M. B., Vanderwall, C., & Witowich, G. (2015) · Nutrition & Dietetics · doi:10.1111/1747-0080.12177 · Cited by 62
CONVENTIONAL AND PROBIOTIC YOGURTS DIFFER IN SENSORY PROPERTIES BUT NOT IN CONSUMERS' PREFERENCES
Majchrzak, D., Lahm, B., & Dürrschmid, K. (2010) · Journal of Sensory Studies · doi:10.1111/j.1745-459x.2009.00269.x · Cited by 56
GUYONNET, D., WOODCOCK, A., STEFANI, B., TREVISAN, C., & HALL, C. (2009) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2008.00366.x · Cited by 45
Jew, S., Vanstone, C. A., Antoine, J., & Jones, P. J. H. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1228s · Cited by 44
Self-citationTabbers, M. M., Chmielewska, A., Roseboom, M. G., Boudet, C., Perrin, C., Szajewska, H., & Benninga, M. A. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-22 · Cited by 46
“Recently, studies have shown that this fermented milk significantly decreased transit time in young and elderly healthy adults [9-13] and in constipation-predominant IBS patients [14].”
BackgroundProbiotics improve bowel movements in hospitalized elderly patients — The proage study
Zaharoni, H., Rimon, E., Vardi, H., Friger, M., Bolotin, A., & Shahar, D. R. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-010-0323-3 · Cited by 35
“Nevertheless, recent studies have shown that probiotics can enhance colonic transit time ( 12 ).”
Nilsson, A., Johansson-Boll, E., Sandberg, J., & Björck, I. (2016) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2016.06.006 · Cited by 30
Hasain, Z., Roos, N. A. C., Rahmat, F., Mustapa, M., Ali, R. A. R., & Mokhtar, N. M. (2021) · Nutrients · doi:10.3390/nu13093045 · Cited by 39
Systematic review of randomised controlled trials
Avenell, A., Robertson, C., Skea, Z. C., Jacobsen, E., Boyers, D., Cooper, D. D. J., Aceves‐Martins, M., Retat, L., Fraser, C. M., Aveyard, P. N., et al. (2018) · Cited by 26
Mukherjee, A., Farsi, D. N., García-Gutiérrez, E., Akan, E., Salas-Millán, J. Á., Angelovski, L., Bintsis, Τ., Gérard, A., Güley, Z., Kabakcı, S. A., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1668889 · Cited by 27
[Lactic Acid Bacteria] Probiotic Lactic Acid Bacteria
Ann, Y.-G. (2011) · The Korean Journal of Food And Nutrition · doi:10.9799/ksfan.2011.24.4.817 · Cited by 25
Perspective: Assessing Tolerance to Nondigestible Carbohydrate Consumption
Holscher, H. D., Chumpitazi, B. P., Dahl, W. J., Fahey, G. C., Jr., Liska, D. J., Slavin, J. L., & Verbeke, K. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac091 · Cited by 25
“…is recommended to account for the amount of time needed for food residues to pass through the whole gut (12, 13); however, longer lead-in periods of 2 to 6 wk may be necessary to ensure adequate washouts of restricted foods or supplements [i.e., probiotics, prebiotics, and synbiotics (36, 37)].”
Tulk, H., Blonski, D. C., Murch, L. A., Duncan, A. M., & Wright, A. J. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-87 · Cited by 25
“DN-173010 (≥10(8) CFU/g) has been shown to improve bowel movement frequency and consistency in women with constipation [9], to decrease initially long GI transit times (GTT) in healthy women [10], men [11] and older adults [12,13], and to improve overall GI well-being and digestive symptoms in healthy women [14].”
BackgroundMethodMalpeli, A., González, S., Vicentin, D., Apás, A. L., & González, H. F. (2013) · PubMed · doi:10.3305/nh.2012.27.4.5770 · Cited by 19
Alimentos funcionales: Fibra, Prebióticos, Probióticos y Simbióticos
Olagnero, G., Bendersky, S., Genevois, C. E., Granzella, L., & Montonati, M. L. (2007) · Diaeta (B. Aires) · Cited by 17
Abdominal Bloating and Distension: What Is the Role of the Microbiota
Issa, B., Wafaei, N. A., & Whorwell, P. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1834-4 · Cited by 14
“physiological studies DN-173-010 has been shown to accelerate gastrointestinal transit [46–49] and, in clinical trials, to reduce the subjective reporting of bloating [37].”
BackgroundBifidobacterium animalis spp. lactis
Quigley, E. M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00013-6 · Cited by 13
Merenstein, D. J., D'Amico, F., Palese, C., Hahn, A., Sparenborg, J., Tan, T., Scott, H., Polzin, K., Kolberg, L., & Roberts, R. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513002237 · Cited by 12
“Another study by Meance et al.(16) on a different B. lactis probiotic found improved transit times, but subjects were randomised by baseline transit times that were considerably slower than normal standards.”
BackgroundInfluentialProbiotics as functional foods: gut colonization and safety concerns
Sarkar, S. (2013) · Nutrition & Food Science · doi:10.1108/nfs-10-2011-0120 · Cited by 9
Segers, C., Mysara, M., Coolkens, A., Baatout, S., Leys, N., Lebeer, S., Verslegers, M., & Mastroleo, F. (2022) · Applied Microbiology · doi:10.3390/applmicrobiol2030049 · Cited by 8
Fecal Microbiota and Probiotic Yogurt Intake
Roy, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805134-4.00013-4 · Cited by 8
Propriétés fonctionnelles des probiotiques
Flourié, B., & Nancey, S. (2007) · Cahiers de Nutrition et de Diététique · doi:10.1016/s0007-9960(07)91320-6 · Cited by 8
Meléndez-Illanes, L., Díaz, C. G., Chilet‐Rosell, E., & Álvarez‐Dardet, C. (2015) · Journal of Public Health · doi:10.1093/pubmed/fdv151 · Cited by 4
Probiotics and its Effect on Slow Colonic Transit
Ouwehand, A. C. (2014) · Journal of Food & Nutritional Disorders · doi:10.4172/2324-9323.s1-001 · Cited by 2
PROBIÓTICOS, PREBIÓTICOS E SIMBIÓTICOS PARA O TRATAMENTO DE CONSTIPAÇÃO EM IDOSOS
Fernandes, A. S., Rodrigues, S. D. S., & de Souza, M. G. A. (2021) · Revista Saúde - UNG-Ser · doi:10.33947/1982-3282-v15n1-2-4506 · Cited by 2
Peña-Ocaña, B. A., Hoshiko, Y., Silva-Flores, M., Maeda, T., Pérez-Torres, I., García‐Contreras, R., Gutiérrez-Sarmiento, W., Hernández‐Esquivel, L., Marín‐Hernández, Á., Sánchez‐Thomas, R., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.949272 · Cited by 2
“Hepatoma induced a decrement of beneficial bacteria such as Prevotella, Faecalibacterium, Lachnospiraceae, Bifidobacterium, and Lactobacillus; these organisms have been proposed as essential in the maintenance of a healthy microbiota because they can improve glucose metabolism and digestion of complex fibers, and some…”
BackgroundSevastyanova, T. V., Usha, B. V., Борисович, Н. С., & Alshevskaya, A. (2025) · Agrarian science · doi:10.32634/0869-8155-2025-400-11-22-32 · Cited by 1
Olagnero, G., Abad-Sojos, A., Bendersky, S., Genevois, C. E., Granzella, L., & Montonati, M. L. (2007) · Cited by 1
Gut Microbiota in Elderly’s Health
Bäuerl, C., Selma‐Royo, M., Mera-Balseca, A. G., Collado, M. C., & Pérez‐Martínez, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_163-1 · Cited by 1
Gut Microbiota in Elderly’s Health
Bäuerl, C., Selma‐Royo, M., Mera-Balseca, A. G., Collado, M. C., & Pérez‐Martínez, G. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_163 · Cited by 2
Functional dairy products for gastrointestinal infections and dysfunction
Myllyluoma, E., Kajander, K., & Saxelin, M. (2007) · Elsevier eBooks · doi:10.1533/9781845693107.1.63 · Cited by 1
The Effects of Complex Lactobacillus on Bowel Function in Nursing Home Elderly
Liu, Y.-L., Yang, S., Huang, C., & Tseng, C. (2010)
Nutrition and Gut Health in Older People
Ouwehand, A. C., Tiihonen, K., Mäkeläinen, H., Lahtinen, S. J., & Rautonen, N. (2009) · Elsevier eBooks · doi:10.1533/9781845695484.2.288
Barley- and Legume Products Beneficially Affect Metabolic Responses and Appetite Regulation
Johansson, E. (2014) · Lund University Publications (Lund University) · Cited by 2
Die Ernährung des Gesunden – ein Beitrag zur Verringerung des Erkrankungsrisikos
Kasper, H. (2014) · Elsevier eBooks · doi:10.1016/b978-3-437-42013-9.00002-6
Principles of Rational Nutrition for Managing Constipation
Shulpekova, Y. O., Sheptulin, D. A., & Shulpekova, N. V. (2018) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2018-28-5-117-125
Metadata
- Authors
- Meance, S., Cayuela, C., Raimondi, A., Turchet, P., Lucas, C., & Antoine, J.-M.
- Affiliations
- Danone Vitapole FR-91767 Palaiseau Cedex
- Danone (France) (FR)
- ISERNT-ALPE ADRIA Trieste
- Venue
- Microbial Ecology in Health and Disease
- Publisher
- Informa UK Limited
- Published
- 2003-01
- Volume
- 15
- Issue
- 1
- Pages
- 15-22
- ISSN
- 0891-060X (ISSN-L)
- 1651-2235
- OpenAlex
- W4232130333
- Semantic Scholar
- 028109485bbbdaca28bbbff5aafe6581bf0cff64
- Cited by
- 44
- References
- 18
- Citations by year
- 2025: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 5
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Microbial Ecology in Health and Disease (publishedVersion, cc-by)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, fermented milk, yogurt, gut transit time, older adults, slow transit constipation, dose-dependent effects, gastrointestinal function, functional foods
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.